Pathology Analysis & Statistics, May 2013 (p50)

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Publishers

All regions

You might be interested in: Cancer, Breast Cancer, Leukemia, more »

1471-1520 of about 4 400 reports

Purchase Reports From Reputable Market Research Publishers

 Psoriatic Arthritis-Pipeline Insights, 2014

Psoriatic Arthritis-Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • August 2014
  • by Delve Insight

SUMMARY DelveInsight's,“ Psoriatic Arthritis-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish ...

  • Industries : Pathology
 Pulmonary Arterial Hypertension-Pipeline Insights, 2014

Pulmonary Arterial Hypertension-Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • August 2014
  • by Delve Insight

SUMMARY DelveInsight's,“ Pulmonary Arterial Hypertension-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report ...

  • Industries : Pathology
 Pulmonary Embolism-Pipeline Insights, 2014

Pulmonary Embolism-Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • August 2014
  • by Delve Insight

SUMMARY DelveInsight's,“ Pulmonary Embolism-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish ...

  • Industries : Pathology
 Pulmonary Hypertension-Pipeline Insights, 2014

Pulmonary Hypertension-Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • August 2014
  • by Delve Insight

SUMMARY DelveInsight's,“ Pulmonary Hypertension-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish ...

  • Industries : Pathology
 Rabies-Pipeline Insights, 2014

Rabies-Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • August 2014
  • by Delve Insight

SUMMARY DelveInsight's,“ Rabies-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding ...

  • Industries : Pathology
 Recurrent Head And Neck Cancer Squamous Cell Carcinoma-Pipeline Insights, 2014

Recurrent Head And Neck Cancer Squamous Cell Carcinoma-Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • August 2014
  • by Delve Insight

SUMMARY DelveInsight's,“ Recurrent Head And Neck Cancer Squamous Cell Carcinoma-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective ...

  • Industries : Pathology
 Recurrent Malignant Glioma -Pipeline Insights, 2014

Recurrent Malignant Glioma -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • August 2014
  • by Delve Insight

SUMMARY DelveInsight's,“ Recurrent Malignant Glioma -Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to ...

  • Industries : Pathology
 Refractory Leukemia-Pipeline Insights, 2014

Refractory Leukemia-Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • August 2014
  • by Delve Insight

SUMMARY DelveInsight's,“ Refractory Leukemia-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish ...

  • Industries : Pathology
 Relapsed Chronic Lymphocytic Leukemia (CLL)-Pipeline Insights, 2014

Relapsed Chronic Lymphocytic Leukemia (CLL)-Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • August 2014
  • by Delve Insight

SUMMARY DelveInsight's,“ Relapsed Chronic Lymphocytic Leukemia (CLL)-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of ...

  • Industries : Pathology
 Relapsed/ Refractory Chronic Lymphocytic Leukemia (CLL)-Pipeline Insights, 2014

Relapsed/ Refractory Chronic Lymphocytic Leukemia (CLL)-Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • August 2014
  • by Delve Insight

SUMMARY DelveInsight's,“ Relapsed/ Refractory Chronic Lymphocytic Leukemia (CLL)-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key ...

  • Industries : Pathology
 Relapsing Multiple Sclerosis (RMS)-Pipeline Insights, 2014

Relapsing Multiple Sclerosis (RMS)-Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • August 2014
  • by Delve Insight

SUMMARY DelveInsight's,“ Relapsing Multiple Sclerosis (RMS)-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report ...

  • Industries : Pathology
 Relapsing Remitting Multiple Sclerosis (RRMS)-Pipeline Insights, 2014

Relapsing Remitting Multiple Sclerosis (RRMS)-Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • August 2014
  • by Delve Insight

SUMMARY DelveInsight's,“ Relapsing Remitting Multiple Sclerosis (RRMS)-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective ...

  • Industries : Pathology
 Renal Anemia-Pipeline Insights, 2014

Renal Anemia-Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • August 2014
  • by Delve Insight

SUMMARY DelveInsight's,“ Renal Anemia-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the ...

  • Industries : Pathology
 Renal Osteodystrophy-Pipeline Insights, 2014

Renal Osteodystrophy-Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • August 2014
  • by Delve Insight

SUMMARY DelveInsight's,“ Renal Osteodystrophy-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish ...

  • Industries : Pathology
 Resistant Hypertension-Pipeline Insights, 2014

Resistant Hypertension-Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • August 2014
  • by Delve Insight

SUMMARY DelveInsight's,“ Resistant Hypertension-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish ...

  • Industries : Pathology
 Respiratory Depression-Pipeline Insights, 2014

Respiratory Depression-Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • August 2014
  • by Delve Insight

SUMMARY DelveInsight's,“ Respiratory Depression-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish ...

  • Industries : Pathology
 Restless Legs Syndrome-Pipeline Insights, 2014

Restless Legs Syndrome-Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • August 2014
  • by Delve Insight

SUMMARY DelveInsight's,“ Restless Legs Syndrome-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish ...

  • Industries : Pathology
 Retinopathy Of Prematurity-Pipeline Insights, 2014

Retinopathy Of Prematurity-Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • August 2014
  • by Delve Insight

SUMMARY DelveInsight's,“ Retinopathy Of Prematurity-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to ...

  • Industries : Pathology
 Rhabdomyosarcoma-Pipeline Insights, 2014

Rhabdomyosarcoma-Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • August 2014
  • by Delve Insight

SUMMARY DelveInsight's,“ Rhabdomyosarcoma-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish ...

  • Industries : Pathology
 Rhino-Conjunctivitis-Pipeline Insights, 2014

Rhino-Conjunctivitis-Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • August 2014
  • by Delve Insight

SUMMARY DelveInsight's,“ Rhino-Conjunctivitis-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish ...

  • Industries : Pathology
 Rhinovirus Infection-Pipeline Insights, 2014

Rhinovirus Infection-Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • August 2014
  • by Delve Insight

SUMMARY DelveInsight's,“ Rhinovirus Infection-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish ...

  • Industries : Pathology
 Rosacea-Pipeline Insights, 2014

Rosacea-Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • August 2014
  • by Delve Insight

SUMMARY DelveInsight's,“ Rosacea-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding ...

  • Industries : Pathology
 Rotavirus Infections-Pipeline Insights, 2014

Rotavirus Infections-Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • August 2014
  • by Delve Insight

SUMMARY DelveInsight's,“ Rotavirus Infections-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish ...

  • Industries : Pathology
 Rubella-Pipeline Insights, 2014

Rubella-Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • August 2014
  • by Delve Insight

SUMMARY DelveInsight's,“ Rubella-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding ...

  • Industries : Pathology
 Sarcomas-Pipeline Insights, 2014

Sarcomas-Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • August 2014
  • by Delve Insight

SUMMARY DelveInsight's,“ Sarcomas-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding ...

  • Industries : Pathology
 Schistosomiasis-Pipeline Insights, 2014

Schistosomiasis-Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • August 2014
  • by Delve Insight

SUMMARY DelveInsight's,“ Schistosomiasis-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish ...

  • Industries : Pathology
 Seasonal Allergic Rhinitis-Pipeline Insights, 2014

Seasonal Allergic Rhinitis-Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • August 2014
  • by Delve Insight

SUMMARY DelveInsight's,“ Seasonal Allergic Rhinitis-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to ...

  • Industries : Pathology
 Secondary Hyperparathyroidism-Pipeline Insights, 2014

Secondary Hyperparathyroidism-Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • August 2014
  • by Delve Insight

SUMMARY DelveInsight's,“ Secondary Hyperparathyroidism-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is ...

  • Industries : Pathology
 Secondary Progressive Multiple Sclerosis (SPMS)-Pipeline Insights, 2014

Secondary Progressive Multiple Sclerosis (SPMS)-Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • August 2014
  • by Delve Insight

SUMMARY DelveInsight's,“ Secondary Progressive Multiple Sclerosis (SPMS)-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective ...

  • Industries : Pathology
 Sepsis-Pipeline Insights, 2014

Sepsis-Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • August 2014
  • by Delve Insight

SUMMARY DelveInsight's,“ Sepsis-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding ...

  • Industries : Pathology

About 200 Companies

Read our Company Profiles

Pfizer Inc.

United States

Novartis Inc.

Switzerland

GlaxoSmithKline PLC

United Kingdom

GlaxoSmithKline P.L.C.

United States

Imaging Systems L.L.C.

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.